Clinical Trial Update: A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on a double-dose safety study of the influenza vaccine Multimeric-001 in healthy volunteers; results completed and posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• Multimeric-001

Snippet

Sponsor: BiondVax Pharmaceuticals ltd. | Conditions: Healthy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-03-27